ZimVie Inc. (NASDAQ:ZIMV) Shares Purchased by Gamco Investors INC. ET AL

Gamco Investors INC. ET AL lifted its position in ZimVie Inc. (NASDAQ:ZIMV) by 6.0% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 343,717 shares of the company’s stock after acquiring an additional 19,459 shares during the period. Gamco Investors INC. ET AL owned 1.26% of ZimVie worth $5,668,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also recently made changes to their positions in ZIMV. Heritage Wealth Advisors increased its holdings in ZimVie by 172,750.0% during the 1st quarter. Heritage Wealth Advisors now owns 6,914 shares of the company’s stock worth $114,000 after purchasing an additional 6,910 shares during the period. Russell Investments Group Ltd. increased its holdings in ZimVie by 0.7% during the 1st quarter. Russell Investments Group Ltd. now owns 281,377 shares of the company’s stock worth $4,640,000 after purchasing an additional 1,964 shares during the period. Rice Hall James & Associates LLC increased its holdings in ZimVie by 1.1% during the 1st quarter. Rice Hall James & Associates LLC now owns 178,114 shares of the company’s stock worth $2,937,000 after purchasing an additional 2,012 shares during the period. Scarborough Advisors LLC purchased a new stake in ZimVie during the 4th quarter worth about $28,000. Finally, CenterBook Partners LP purchased a new stake in ZimVie during the 4th quarter worth about $988,000. 95.63% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Separately, Needham & Company LLC reiterated a “buy” rating and issued a $20.00 price objective on shares of ZimVie in a report on Tuesday, June 25th.

ZimVie Stock Down 0.2 %

Shares of ZIMV traded down $0.04 during mid-day trading on Friday, reaching $21.67. The company’s stock had a trading volume of 410,117 shares, compared to its average volume of 394,963. ZimVie Inc. has a 12-month low of $6.52 and a 12-month high of $22.40. The stock has a market cap of $591.37 million, a PE ratio of -1.55 and a beta of 2.17. The company has a debt-to-equity ratio of 1.32, a current ratio of 2.68 and a quick ratio of 2.23. The company’s 50 day moving average is $17.74 and its 200 day moving average is $17.44.

ZimVie (NASDAQ:ZIMV) last released its quarterly earnings data on Wednesday, May 8th. The company reported $0.08 EPS for the quarter. ZimVie had a positive return on equity of 2.01% and a negative net margin of 56.31%. The business had revenue of $118.20 million for the quarter. During the same quarter in the previous year, the company posted $0.25 EPS. Equities analysts anticipate that ZimVie Inc. will post 0.63 EPS for the current fiscal year.

ZimVie Profile

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.